XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

TROVA, SALVA E MONITORA I TUOI INVESTIMENTI CON LA WATCHLIST DI CBONDS

Attraverso la Watchlist di Cbonds puoi rimanere sempre aggiornato sui tuoi investimenti per prendere decisioni consapevoli!

Watchlist

Per visualizzare questi dati è necessario un abbonamento

Cbonds API

Integra i dati di mercato nei tuoi sistemi

Accedi ai dati su ETF e fondi comuni di investimento tramite API

Prezzi e NAV
Struttura del fondo
Afflussi e dividendi

Seleziona tutto Ripristina i parametri

Salva Chiudi

(%)

US78464A8707

XBI ISIN

Exchange Traded Funds (ETF)

Tipologia di fondo

SPDR State Street Global Advisors

Provider

156,87 USD

NAV per azione | 10/09/2026

31/01/2006

Data di inizio

4 volte l'anno

Pagamento dei dividendi

CEOILS

CFI

XBI

Ticker

Formed

Status

Equity

Oggetto d'investimento

Biotech

Settore

USA

Geografia

S&P Biotechnology Select Industry Index

Benchmark

0.35 %

Rapporto costo totale

10.569,39 ml USD

Totale attivo del fondo | 10/09/2026

10.569,39 ml USD

Attività della classe azionaria | 10/09/2026

UCITS

1 / 3 (11/09/2015)

Diviso

7-giorni Accesso di prova

Ottieni l'accesso completo al nostro database
Utilizza il nostro potente bond screener
Traccia i prezzi dei bond da oltre 400 fonti primarie
Monitora tutti i tuoi titoli quotidianamente

Accedi ai dati

Redditività su 11/09/2026, NYSE Arca

YTD

28,66 %
1M

-1,18 %
3M

17,78 %
6M

23,71 %
1Y

64,3 %
3Y

99,37 %
5Y

19,32 %
10Y

158,63 %

Al prezzo di scambio, tenendo conto dei pagamenti di reddito

Ultimi dati di

Aggiungi da confrontare

Quote (XBI)

Utilizza il più completo database finanziario

1 000 000

obbligazioni

100 000

azioni

175 910

ETF & Funds

100 000

indici

Monitora il tuo portafoglio nel modo più efficiente

Bond screener
Watchlist
Excel ADD-IN

Ottieni l'accesso

Prova di 7-giorni Accesso demo

Ottieni accesso a tutto il nostro database
Fai Screening come un vero professionista
Monitora tutti i tuoi titoli quotidianamente
Traccia i prezzi dei bond da oltre 400 fonti
Prendi decisioni ponderate, basate su dati accurati e completi

Filtra i bond in base a +50 criteri (rating, rendimento, prezzo, ecc.)

Ottieni l'accesso

Dinamica dei prezzi

Profilo fondo

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profilo

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Struttura XBI su 10/09/2026

Scarica la struttura in Excel

Documento	Valore
MODERNA INC	2,87%
TWIST BIOSCIENCE CORP	1,81%
HALOZYME THERAPEUTICS INC	1,47%
NATERA INC	1,46%
KYMERA THERAPEUTICS INC	1,45%
TRAVERE THERAPEUTICS INC	1,4%
ROIVANT SCIENCES LTD	1,39%
ORUKA THERAPEUTICS INC	1,38%
REVOLUTION MEDICINES INC	1,36%
PRAXIS PRECISION MEDICINES I	1,36%
INSMED INC	1,34%
PROTAGONIST THERAPEUTICS INC	1,33%
DIANTHUS THERAPEUTICS INC	1,31%
REGENERON PHARMACEUTICALS	1,27%
CG ONCOLOGY INC	1,27%
VAXCYTE INC	1,25%
SUMMIT THERAPEUTICS INC	1,23%
SCHOLAR ROCK HOLDING CORP	1,22%
ERASCA INC	1,16%
RELAY THERAPEUTICS INC	1,16%
RHYTHM PHARMACEUTICALS INC	1,15%
GILEAD SCIENCES INC	1,15%
TG THERAPEUTICS INC	1,15%
IOVANCE BIOTHERAPEUTICS INC	1,15%
SPYRE THERAPEUTICS INC	1,14%
VERTEX PHARMACEUTICALS INC	1,14%
SELLAS LIFE SCIENCES GROUP I	1,13%
ARROWHEAD PHARMACEUTICALS IN	1,13%
INCYTE CORP	1,13%
BIOMARIN PHARMACEUTICAL INC	1,13%
VIKING THERAPEUTICS INC	1,12%
ABBVIE INC	1,1%
AMGEN INC	1,09%
MADRIGAL PHARMACEUTICALS INC	1,09%
GRAIL INC	1,07%
BIOGEN INC	1,07%
ACADIA PHARMACEUTICALS INC	1,07%
KRYSTAL BIOTECH INC	1,07%
CYTOKINETICS INC	1,06%
EXELIXIS INC	1,06%
COGENT BIOSCIENCES INC	1,05%
BRIDGEBIO PHARMA INC	1,04%
UNIQURE NV	1,03%
MIRUM PHARMACEUTICALS INC	1,03%
CRISPR THERAPEUTICS AG	1,02%
ALKERMES PLC	1,02%
IMMUNOVANT INC	0,95%
NEUROCRINE BIOSCIENCES INC	0,94%
CELCUITY INC	0,94%
IMMUNITYBIO INC	0,94%
UNITED THERAPEUTICS CORP	0,89%
SAREPTA THERAPEUTICS INC	0,89%
PTC THERAPEUTICS INC	0,89%
VERA THERAPEUTICS INC	0,86%
VIRIDIAN THERAPEUTICS INC	0,85%
IDEAYA BIOSCIENCES INC	0,84%
ALNYLAM PHARMACEUTICALS INC	0,82%
MINERALYS THERAPEUTICS INC	0,8%
BEAM THERAPEUTICS INC	0,8%
BIOCRYST PHARMACEUTICALS INC	0,77%
CELLDEX THERAPEUTICS INC	0,75%
DYNE THERAPEUTICS INC	0,74%
IONIS PHARMACEUTICALS INC	0,73%
IMMUNOME INC	0,73%
DENALI THERAPEUTICS INC	0,72%
ADMA BIOLOGICS INC	0,71%
DISC MEDICINE INC	0,69%
NOVAVAX INC	0,68%
RECURSION PHARMACEUTICALS A	0,68%
HYPERLIQUID STRATEGIES	0,68%
INTELLIA THERAPEUTICS INC	0,67%
ARCUTIS BIOTHERAPEUTICS INC	0,66%
ARCUS BIOSCIENCES INC	0,66%
TANGO THERAPEUTICS INC	0,66%
AGIOS PHARMACEUTICALS INC	0,65%
SYNDAX PHARMACEUTICALS INC	0,64%
NURIX THERAPEUTICS INC	0,62%
VERACYTE INC	0,61%
PALVELLA THERAPEUTICS INC	0,6%
CAREDX INC	0,56%
ULTRAGENYX PHARMACEUTICAL IN	0,51%
VIR BIOTECHNOLOGY INC	0,51%
CULLINAN THERAPEUTICS INC	0,49%
KODIAK SCIENCES INC	0,48%
BIOHAVEN LTD	0,47%
PRECIGEN INC	0,46%
XENCOR INC	0,46%
STOKE THERAPEUTICS INC	0,45%
VERICEL CORP	0,44%
INHIBRX BIOSCIENCES INC	0,43%
ANAPTYSBIO INC	0,42%
ABSCI CORP	0,41%
ZENAS BIOPHARMA INC	0,41%
ORIC PHARMACEUTICALS INC	0,38%
VOR BIOPHARMA INC	0,38%
CORVUS PHARMACEUTICALS INC	0,37%
REPLIMUNE GROUP INC	0,35%
KURA ONCOLOGY INC	0,35%
FIRST TRACKS BIOTHERAPEUTICS	0,34%
AVALO THERAPEUTICS INC	0,34%